You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Biotech venture valuation workbench: reflexivity-adjusted PoS, phase-stratified ML prior trained on real HINT outcomes (externally validated against CT Open uncontaminated), phase-gated rNPV with Monte Carlo, 8-pillar diligence scorecard, cited deal comparables. Modular registry architecture with three runtime agents.